---
title: "iNotify ApS – CVR 42686107, financials and ownership"
description: "iNotify ApS (CVR 42686107). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · København N. 4 employees (CVR) (Jul 2026). Gross profit -40.2K EUR (2025)."
canonical_url: "https://datapublica.dk/en/companies/42686107-inotify-aps"
locale: "en"
route_type: "company_overview"
robots: "index,follow"
---

# iNotify ApS

iNotify ApS \(CVR 42686107\). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · København N. 4 employees \(CVR\) \(Jul 2026\). Gross profit -40.2K EUR \(2025\).

CVR number: 42686107

## Company details

- **CVR number:** 42686107

- **Status:** Aktiv

- **Address:** Ole Maaløes Vej 3, 2200, København N

- **Legal form:** Anpartsselskab \(ApS\)

- **Founded:** Sep 17, 2021

- **Employees / FTEs:** 4 / 3

- **Production units:** 1

## Description

Notify Therapeutics is engaged in the discovery and development of drug products for treating infertility in women, based on the foundational science and intellectual property around new NTY series, which can utilize a new mechanism to promote egg formation and increase life birth.

## Activities and industry

- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

- 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

## Latest financial period

- **Reporting period:** 2025

- **Currency:** EUR

- **Gross profit:** -40,215

- **Operating profit:** -514,098

- **Profit after tax:** -386,474

- **Assets:** 735,834

- **Equity:** 691,981

## Founders

| Founder | Registered as founder | Current roles | Ownership |
| --- | --- | --- | --- |
| [Anders Heuck](https://datapublica.dk/en/people/pid_entity_4009007501-anders-heuck) | Sep 17, 2021 | — | — |
| [Emil Hagen Ernst](https://datapublica.dk/en/people/pid_entity_4009007502-emil-hagen-ernst) | Sep 17, 2021 | — | — |
| [Karin Lykke-Hartmann](https://datapublica.dk/en/people/pid_entity_4009007499-karin-lykke-hartmann) | Sep 17, 2021 | Management | 33.33–49.99 % / Indirect via [Karin Lykke-Hartmann Holding ApS](https://datapublica.dk/en/companies/42837717-karin-lykke-hartmann-holding-aps) |
| [Mahboobeh Amoushahi](https://datapublica.dk/en/people/pid_entity_4009007500-mahboobeh-amoushahi) | Sep 17, 2021 | — | — |

## People

| Person | Roles | Titles |
| --- | --- | --- |
| [Henrik Stage](https://datapublica.dk/en/people/pid_entity_4000483314-henrik-stage) | Board | BESTYRELSESMEDLEM |
| [Jacob Falck Hansen](https://datapublica.dk/en/people/pid_entity_4000413129-jacob-falck-hansen) | Board | BESTYRELSESMEDLEM |
| [Karin Lykke-Hartmann](https://datapublica.dk/en/people/pid_entity_4009007499-karin-lykke-hartmann) | Management | ADM. DIR. |

## Auditor

| Audit firm | Auditor | Role | From |
| --- | --- | --- | --- |
| EY Godkendt Revisionspartnerselskab | Peter U. Faurschou | State Authorised Public Accountant | Jun 22, 2026 |

## Legal owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerKarin Lykke-Hartmann Holding ApS | Ownership33.33–49.99 % | Voting rights33.33 % | FromSep 26, 2023 |
| OwnerBII Holdings A/S | Ownership15–19.99 % | Voting rights15 % | FromMar 20, 2024 |
| OwnerLUNDBECKFOND INVEST A/S | Ownership10–14.99 % | Voting rights10 % | FromSep 26, 2023 |
| OwnerNanoDimension IV, L.P. | Ownership10–14.99 % | Voting rights10 % | FromSep 26, 2023 |
| OwnerNext Stage Ventures ApS | Ownership5–9.99 % | Voting rights5 % | FromOct 28, 2022 |

### Previous

| Owner | Ownership | Voting rights | From | To |
| --- | --- | --- | --- | --- |
| OwnerBioInnovation Institute Fonden | Ownership15–19.99 % | Voting rights15 % | FromSep 26, 2023 | ToMar 20, 2024 |
| OwnerKarin Lykke-Hartmann Holding ApS | Ownership66.67–89.99 % | Voting rights66.67 % | FromMar 1, 2023 | ToSep 25, 2023 |
| OwnerKarin Lykke-Hartmann Holding ApS | Ownership90–99.99 % | Voting rights90 % | FromNov 21, 2021 | ToFeb 28, 2023 |
| OwnerKarin Lykke-Hartmann | Ownership90–99.99 % | Voting rights90 % | FromSep 17, 2021 | ToNov 21, 2021 |

## Ultimate owners
[View ownership diagram](https://datapublica.dk/en/companies/42686107-inotify-aps/portfolio)
| Name | Ownership through | Calculated ownership |
| --- | --- | --- |
| Karin Lykke-Hartmann | Karin Lykke-Hartmann Holding ApS | 33.33–49.99 % |
| BioInnovation Institute Fonden | BII Holdings A/S | 15–19.99 % |
| LUNDBECKFONDEN | LUNDBECKFOND INVEST A/S | 10–14.99 % |
| NanoDimension IV, L.P. | Direct | 10–14.99 % |
| Henrik Stage | Next Stage Ventures ApS | 5–9.99 % |

## Company pages

- [Overview](https://datapublica.dk/en/companies/42686107-inotify-aps)

- [Financial report](https://datapublica.dk/en/companies/42686107-inotify-aps/financials)

- [Risk](https://datapublica.dk/en/companies/42686107-inotify-aps/risk)

- [Timeline](https://datapublica.dk/en/companies/42686107-inotify-aps/timeline)

- [Ownership and relations](https://datapublica.dk/en/companies/42686107-inotify-aps/portfolio)

- [Production units](https://datapublica.dk/en/companies/42686107-inotify-aps/production-units)

- [Gazelle](https://datapublica.dk/en/companies/42686107-inotify-aps/gazelle)

- [Investments](https://datapublica.dk/en/companies/42686107-inotify-aps/investments)

## Official sources

- [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/42686107)